Injections of botulinum toxin improved active arm movement for stroke and brain trauma patients in a clinical trial that involved Northwestern Medicine co-investigator Christina Marciniak, MD, ’85 GME.
Menu
Browsing: Clinical Breakthroughs
Children with allergic disease have about twice the rate of high blood pressure and high cholesterol, according to a new Northwestern Medicine study.
Karl Bilimoria, MD, director of the Northwestern Surgical Outcomes and Quality Improvement Center, discusses his team’s research to elevate the quality of care patients receive.
A clinical trial led by Northwestern Medicine scientist Mihai Gheorghiade, MD, opens the door for further investigation of a new drug to treat the more than one million patients in the United States hospitalized for heart failure every year.
Northwestern Medicine scientists have identified a novel strategy for reducing the side effects of the drug levodopa, which is commonly used to treat the stiffness, tremors and poor muscle control of Parkinson’s disease.
People who ate more fruits and vegetables as young adults were less likely to develop coronary atherosclerosis 20 years later, according to a recent study co-authored by Northwestern Medicine investigator Philip Greenland, MD.
SchizConnect, the first neuroimaging meta-database dedicated to clinical schizophrenia research, will allow scientists to see broader results across many more subjects than ever before.
Francis Giles, MD, chief of Hematology/Oncology in the Department of Medicine, led a clinical study to test the efficacy and safety of a kinase inhibitor for the treatment of chronic myeloid leukemia.
Nina Gotteiner, MD, associate professor of Pediatrics in the Division of Cardiology, studied the outcomes and predictors of fetuses diagnosed with Epstein anomaly or tricuspid valve dysplasia.
Many patients on antihypertensive medications are at greater risk of cardiovascular disease, despite controlled numbers, according to a new Northwestern Medicine study.